RegMed XB stands for Regenerative Medicine Crossing Borders. It is a virtual institute of Dutch and Flemish public (universities and governments) and private (health foundations and companies) partners that will work together to develop regenerative medicine solutions to health challenges. RegMed XB works on providing regenerative solutions for kidney failure, diabetes type 1, osteoarthritis and heart failure. Next to that, the RegMed XB pilot factory makes it possible to execute scaling steps towards GMP grade product. We believe that when researchers and entrepreneurs work side by side, we stand the best chance to bring the most impact to patients and society at large.